PriyaSehgalMDMS, MPH

Gastroenterology • Philadelphia, PA

Inflammatory Bowel Disease

Assistant Professor of Medicine

Join to view full profile

Dr. Sehgal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sehgal's full profile

Already have an account?

Office
1101 Chestnut St
Philadelphia, PA 19107
Phone+1 215-955-8900

Fax+1 215-955-5245

Education & Training

University of PennsylvaniaAdvanced GI Fellowship, Inflammatory Bowel Disease, 2023 - 2024
New York Presbyterian Hospital (Columbia Campus)Fellowship, Gastroenterology, 2020 - 2023
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2017 - 2020
Icahn School of Medicine at Mount SinaiClass of 2016

Certifications & Licensure

NJ State Medical License 2024 - 2025
NY State Medical License 2020 - 2025
PA State Medical License 2023 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

5 citations
Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Priya Sehgal, Steven Su, John Zech, Yael Nobel, Lyndon Luk
Inflammatory Bowel Diseases. 2024-04-03
42 citations
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
Bo Shen, Gursimran Kochhar, David T. Rubin, Sunanda V. Kane, Udayakumar Navaneethan
The Lancet. Gastroenterology & Hepatology. 2021-11-10
77 citations
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
Bo Shen, Gursimran Kochhar, Revital Kariv, Xiuli Liu, Udayakumar Navaneethan
The Lancet. Gastroenterology & Hepatology. 2021-10-01

Press Mentions

Study Finds GLP-1s Safe and Effective For Managing Obesity in Patients with IBDNovember 18th, 2024